The cDNA Synthesis Market is segmented by application, with gene expression analysis and next-generation sequencing (NGS) representing the largest and most dynamic segments. According to the Wise Guy Reports analysis, these applications are driving significant market growth, fueled by the increasing demand for tools that enable researchers to understand the complex language of the genome.

Gene expression analysis is the largest application segment, with the report projecting it to reach a valuation of USD 1.32 billion by 2028, exhibiting a CAGR of 10.6%. This segment's dominance is driven by the fundamental importance of understanding which genes are active in a given cell or tissue under specific conditions. cDNA synthesis is the essential first step in quantifying gene expression levels, enabling researchers to study everything from normal development to disease progression. The ability to measure the expression of thousands of genes simultaneously has made gene expression analysis a cornerstone of modern biomedical research. The growing focus on understanding the molecular mechanisms of diseases like cancer, cardiovascular disorders, and neurological conditions is driving continued demand for robust and accurate gene expression analysis tools.

Next-generation sequencing (NGS) is the fastest-growing application segment, with the report projecting it to grow at a CAGR of 9.8% and reach a market size of USD 1.15 billion by 2028. NGS technologies have transformed genomics by enabling the rapid sequencing of entire genomes and transcriptomes. cDNA synthesis is a critical step in the NGS workflow, as it converts RNA into cDNA libraries that can be sequenced to reveal information about gene expression, alternative splicing, and the presence of fusion genes. The increasing adoption of NGS in clinical diagnostics, particularly in oncology for tumor profiling and liquid biopsies, is a major driver of demand for cDNA synthesis products. As the cost of NGS continues to decline and its applications expand, the demand for high-quality cDNA synthesis solutions will continue to grow.

Other application segments, including SNP genotyping and microarray analysis, also contribute to the market. SNP genotyping, which is used to identify single nucleotide variations in the genome, is projected to grow at a CAGR of 8.5% and reach USD 0.98 billion by 2028. Microarray analysis, while a more established technology, continues to be used for high-throughput gene expression and genotyping studies, with a projected valuation of USD 0.76 billion by 2028. Together, these applications underscore the versatility of cDNA synthesis as a foundational technology that supports a wide range of genomic investigations.